CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-18 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −6,355 | 12,709 | ||
| 2024-02-18 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +6,355 | 108,068 | ||
| 2024-02-18 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −1,869 | $32.18 | $60K | 106,199 |
| 2024-02-18 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −6,355 | 12,709 | ||
| 2024-02-15 | LAURENCIN CATO T Director | Option exercise 10b5-1 | +2,690 | $22.52 | $61K | 17,859 |
| 2024-02-15 | LAURENCIN CATO T Director | Sale 10b5-1 | −2,690 | $31.85 | $86K | 15,169 |
| 2024-02-15 | LAURENCIN CATO T Director | Option exercise · Non Qualified Stock Option (Right to Buy) 10b5-1 | −2,690 | 18,833 | ||
| 2024-02-10 | MCKEON BRIAN P Director | Option exercise | +4,533 | 24,229 | ||
| 2024-02-10 | MCKEON BRIAN P Director | Shares withheld for taxes | −1,088 | $27.32 | $30K | 23,141 |
| 2024-02-10 | MCKEON BRIAN P Director | Option exercise · Restricted Stock Unit Award | −4,533 | 0 | ||
| 2024-02-10 | Daglio David Angelo Jr. Director | Option exercise | +4,533 | 24,229 | ||
| 2024-02-10 | Daglio David Angelo Jr. Director | Shares withheld for taxes | −1,088 | $27.32 | $30K | 23,141 |
| 2024-02-10 | Daglio David Angelo Jr. Director | Option exercise · Restricted Stock Unit Award | −4,533 | 0 | ||
| 2024-02-08 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award | +36,835 | 150,952 | ||
| 2024-02-08 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −11,007 | $26.77 | $295K | 139,945 |
| 2024-02-08 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award | +218,551 | 1,271,432 | ||
| 2024-02-08 | POPS RICHARD F Director and CEO, Alkermes plc | Shares withheld for taxes | −91,757 | $26.77 | $2.5M | 1,179,675 |
| 2024-02-08 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award | +27,012 | 69,941 | ||
| 2024-02-08 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −8,135 | $26.77 | $218K | 61,806 |
| 2024-02-08 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Grant or award | +21,485 | 271,927 |
Page 29 of 41 · 804 trades